---
schema_version: "secwatch.filing_event.v1"
accession: "0001638833-23-000019"
form_type: "8-K"
ticker: "SGRY"
cik: "0001638833"
company_name: "Surgery Partners, Inc."
filed_at: "2023-03-01T23:59:59+00:00"
generated_at: "2026-06-18T18:05:19.771713+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Surgery Partners Q4 revenue up 15.9% to $707.1M; sets 2023 EBITDA guidance >$425M

## Summary
- Revenue $707.1M in Q4 (+15.9% YoY); full-year revenue $2.5B (+14.1%).
- Net loss attributable to common $23.4M in Q4; full-year net loss $54.6M.
- Adjusted EBITDA $120.8M in Q4 (+5.6% YoY); full-year $380.2M (+12.0%).
- Days adjusted same-facility revenue +10.7% in Q4; +7.7% for full year.
- 2023 guidance: revenue >$2.75B, Adjusted EBITDA >$425M; liquidity >$830M.

## SEC filing metadata
- accession: 0001638833-23-000019
- form_type: 8-K
- ticker: SGRY
- cik: 0001638833
- company_name: Surgery Partners, Inc.
- filed_at: 2023-03-01T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1638833/000163883323000019/0001638833-23-000019-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1638833/000163883323000019/sgry-20230301.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001638833-23-000019
- JSON: https://secwatch.observer/filing/0001638833-23-000019.json
- Plain text: https://secwatch.observer/filing/0001638833-23-000019.txt

## Key facts
- Earnings Releases
  Surgery Partners, Inc. reported full year 2023 results: revenue greater than $2.75 billion. Guidance raised.
  - Period: full year 2023
  - Revenue: greater than $2.75 billion
  - Guidance: raised
  - Result: guidance update
  source text: The Company projects 2023 revenues to be greater than $2.75 billion, and projects 2023 Adjusted EBITDA to be greater than $425 million.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1638833/000163883323000019/0001638833-23-000019-index.htm
- Earnings Releases
  Surgery Partners, Inc. reported financial results for fourth quarter ended December 31, 2022.
  - Period: fourth quarter ended December 31, 2022
  - Result: reported results
  source text: Revenue for the fourth quarter of 2022 increased 15.9% to $707.1 million from $610.2 million for the fourth quarter of 2021.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1638833/000163883323000019/0001638833-23-000019-index.htm
- Earnings Releases
  Surgery Partners, Inc. reported financial results for fourth quarter ended December 31, 2022.
  - Period: fourth quarter ended December 31, 2022
  - Result: reported results
  source text: For the fourth quarter of 2022, the Company’s 1 net loss attributable to common stockholders and Adjusted EBITDA were $23.4 million and $120.8 million, respectively, compared to $0.1 million and $114.4 million for the same period last year.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1638833/000163883323000019/0001638833-23-000019-index.htm
- Earnings Releases
  Surgery Partners, Inc. reported financial results for full year ended December 31, 2022.
  - Period: full year ended December 31, 2022
  - Result: reported results
  source text: Revenue for 2022 increased 14.1% to $2,539.3 million from $2,225.1 million in 2021.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1638833/000163883323000019/0001638833-23-000019-index.htm
- Earnings Releases
  Surgery Partners, Inc. reported financial results for full year ended December 31, 2022.
  - Period: full year ended December 31, 2022
  - Result: reported results
  source text: For the full year 2022, the Company’s net loss attributable to common stockholders and Adjusted EBITDA was $54.6 million and $380.2 million, respectively, compared to $81.2 million and $339.6 million in 2021.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1638833/000163883323000019/0001638833-23-000019-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.